NEW YORK ( TheStreet) -- Staar Surgical (Nasdaq: STAA) hit a new 52-week high Friday as it is currently trading at $9.68, above its previous 52-week high of $9.63 with 328,010 shares traded as of four p.m. ET. Average volume has been 366,800 shares over the past 30 days. Staar Surgical has a market cap of $329.9 million and is part of the services sector and wholesale industry. Shares are up 54.3% year to date as of the close of trading on Thursday. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the cataracts and refractive surgery.
Practice your STAA trading strategies and win cash in our stock game.
TheStreet Ratings rates Staar Surgical as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Staar Surgical Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.